APOC2 and hypertriglyceridemia: Genetic deletion of ApoC2 impairs the ability of LPL to break down lipoproteins that are rich in triglycerides, resulting in a significant increase in plasma triglyceride levels and eventually causing severe hypertriglyceridemia and spontaneous atherosclerosis (40, 41).